Taking place between 12-15 November 2024 in-person in Lisbon, you will also learn about the central role regulatory affairs plays in healthcare companies and the development cycle of new drugs.
This course is ideal for those who are new to regulatory affairs and looking for a comprehensive understanding of the pharmaceuticals industry, as well as established professionals looking to refresh and expand their knowledge.
Get essential insights from our expert speakers who will include Vicky Abbott from Sapienta Regulatory Services Ltd, Kora Doorduyn-van der Stoep from the Medical Evaluation Board (MEB), Arthur Merlin D'Estreux from Jazz Pharmaceuticals, Andrew Modley from Teva, Esther Nougier from Boehringer Ingelheim, Jan Ohotski and Kate Smoter from Medpace), Elizabeth Soames from Scendea, Nicholas Sweeney from Jazz Pharmaceuticals and Hans van Bruggen from Celegence.
By attending this course, you will:
✅ Gain the practical skills you need to become a highly effective regulatory affairs professional
✅ Take part in four interactive days with a comprehensive range of topics and case studies
✅ Develop a network to support you for the rest of your career
✅ Learn from expert speakers with practical knowledge and experience
✅ Earn 30 CPD hours
This course is Module 0 in our MSc programme developed and delivered by a faculty of expert speakers and validated by the University of Hertfordshire
TOPRA members are eligible for discounted rates, as are professionals based in low-income countries (as defined by the World Bank), those working for regulatory or government agencies, academic institutions, charities, patient groups, or in fulltime education.
